News

SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and ...
"AdvantageGo is expected to enable Sapiens to enhance its proposition to the London Specialty Market - a global hub for ...
At the recent Mint Horizons masterclass in Bangalore, a compelling narrative emerged around the urgent need for Indian ...
Bengaluru (Karnataka) [India], April 22: ABB India's campus in Nelamangala, Bangalore, has achieved Mission to Zero ... ABB's ...
Looking for substantial dividend income in unusual places? These three Nasdaq-100 companies offer impressive yields with varied levels of risk and reward. So, you're looking for high-yield ...
A wall of worry, highlighted by uncertainty concerning President Trump's tariffs, has pushed the Dow and S&P 500 into correction territory and the Nasdaq Composite into a full-blown bear market.
The stock market will be closed on April 18 in observance of Good Friday. Both the New York Stock Exchange and the Nasdaq will pause operations for the religious holiday. Trading will resume on ...
Classover Holdings Inc (Nasdaq: KIDZ), a New York-based EdTech company providing live online courses for K-12 students worldwide, visits the Nasdaq MarketSite in Times Square. The company is ...
Junjie Zhang, Founder, Chairman of the Board, and CEO; and Hongfei Huang (Aaron), CFO; were joined by partners and friends of the Company at The Nasdaq MarketSite. “Since founding CHAGEE in 2017 ...
At 12:08 PM EDT, the Dow Jones fell 0.52%, the S&P 500 fell 1.24%, the Nasdaq Composite dropped 2.13%. At 10:47 AM EDT, the Dow Jones fell 0.41%, the S&P 500 fell 1.05%, the Nasdaq Composite ...
Nasdaq-100, tracking 100 large non-financial stocks, is ideal for growth-focused investing. Over a decade, Nasdaq-100's performance topped S&P 500, aiding superior investment returns. Investors ...
Tvardi Therapeutics, Inc. (Nasdaq: TVRD), a clinical-stage biopharmaceutical company developing novel STAT3 inhibitors for fibrosis-driven diseases, visits the Nasdaq MarketSite in Times Square.